EPI-Q assists life sciences firms in demonstrating the value of medical technology and enhancing the quality of clinical practice in order to improve patient care. We help biopharmaceutical firms generate evidence to support product commercialization. EPI-Q is unique because our experts have been on the front line as healthcare decision-makers – treating patients, implementing practice guidelines, measuring quality improvement, and securing access to evidence-based medicine. Let us show you how our team can help you exceed your customers' highest expectations and achieve your most ambitious goals.

View the full range of offerings within our departments.

EPI-Q participates as Silver Sponsor in the upcoming Health Outcomes Research and Pharmacoeconomics Conference, January 28-29, in Arlington, VA

Dr. Mark Jewell, EPI-Q President, and Dr. Ron Kessler, Professor of Health Care Policy at Harvard Medical School, to present on “Building Value Through Health Economics and Outcomes Research in a New Payer Environment”.

For more information on the symposium, click here.

More news...
Enter your email address to get our latest
news and events info as soon as it is announced.